RxDoctor Payments Data

Dorothy Wilhelm, MD

Family Medicine · Monroeville, PANPI 1841476124

Payments from drug & device makers

$761in general payments, 2019–2025

Across 39 payments — averaging $19.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$277
  • Pfizer$104
  • Lilly USA, LLC$85
  • Exact Sciences$52
  • Novo Nordisk$51
  • Amgen$47
  • plus $144 from 5 others

What the payments were for

  • Food & beverage$73797%
  • Education$243%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$761 in reported general payments places this provider in the 65th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$101,227
Medicare patients
257
Services billed
1,196

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide115$192,401
EliquisApixaban149$136,139
JardianceEmpagliflozin91$110,038
TrulicityDulaglutide82$100,563
MounjaroTirzepatide52$72,186
MyrbetriqMirabegron44$44,764
Trelegy ElliptaFluticasone/Umeclidin/Vilanter42$36,453
Breo ElliptaFluticasone/Vilanterol80$36,171
ProliaDenosumab20$34,958
XareltoRivaroxaban22$24,333
FarxigaDapagliflozin Propanediol15$23,568
TradjentaLinagliptin30$22,251
Tresiba Flextouch U-100Insulin Degludec43$20,948
Valsartan356$9,848
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr23$9,742

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$51$192,401115 claims
Lilly USA, LLCTrulicity, Mounjaro$85$172,749134 claims
PfizerEliquis$104$136,139149 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$41$82,366145 claims
AmgenProlia$47$34,95820 claims
AstraZenecaFarxiga$19$23,56815 claims
AbbVieSynthroid$277$8,560135 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Monroeville

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →